Introduction
Mitochondria, intracellular organelles possibly evolved as endosymbiotes of primitive eukaryotes, 1 are widely known as the 'energy factory' of the cell, but also play fundamental roles in intermediary metabolism (i.e., lipid, amino acid, Krebs and urea cycles), steroid hormone and heme biosyntheses, calcium signaling, generation of radical oxygen species (ROS), and programmed cell death (apoptosis). 2 Mitochondria are also the only subcellular structures in animal cells, other than the nucleus, to possess a distinct DNA (mitochondrial DNA (mtDNA)) and gene transcription and translation machineries. Yet, most mitochondrial proteins (more than 1000 according to recent proteomic studies) are encoded by the nuclear DNA (nDNA), synthesized by ribosomes in the cytoplasm, and imported into the organelles after processing through a specific
The Pharmacogenomics Journal (2006) 6, 333-342 & 2006 Nature Publishing Group All rights reserved 1470-269X/06 $30.00 www.nature.com/tpj mechanism. 3 Nuclear genes encode the majority of the respiratory chain polypeptides, 4 as well as several essential factors required for mtDNA transcription and translation (i.e., mitochondrial polymerase g, TFAM, TFBM1 and TFBM2) and induction of apoptosis. [5] [6] [7] The highly integrated cross-functionality of the nuclear and mitochondrial genomes is essential for maintenance of cellular homeostasis. Consequently, defects in nDNA and/or mtDNA-encoded genes can have deleterious effects on almost every organ and function of the human body.
Mutations in mitochondria-related nuclear genes have been described in a variety of rare primary mitochondrial disorders (i.e., Leigh syndrome, Friedreich's ataxia, lethal infantile cardiomyopathy, carnitine palmitoyl transferase deficiency, to name a few). 8, 9 Additionally, genetic, structural, and functional abnormalities of mitochondria are increasingly recognized in a variety of medical states with high morbidity and/or mortality, such as cancer, obesity, diabetes, cardiomyopathy, neurodegenerative disorders, infertility and migraine, as well as in normal aging. [10] [11] [12] [13] Finally, many chemicals and therapeutic agents (i.e., antineoplastic, immunosuppressant, anti-inflammatory and antiviral drugs, potassium-channel openers, sulfonylureas and anesthetics) affect mitochondrial function, often causing severe mitochondrial toxicity.
14 Thus, the ability to study the transcriptional behavior of the entire complement of mitochondrial genes could have a major impact on biomedical research, as it might help identify new genomic targets for understanding disease pathogenesis and improving diagnosis, prevention and treatment.
The critical role of mitochondria in skeletal muscle pathophysiology is highlighted by the distinctive myopathic changes commonly associated with mitochondrial genetic disorders. 15 Skeletal muscle myopathy, presenting as loss of muscle mass, strength and/or function, is also a debilitating complication of prolonged excess of endogenous or exogenous glucocorticoids; yet, its underlying mechanisms are largely unexplored, and targeted therapeutic interventions remain limited. [16] [17] [18] Although a concomitant decrease in protein biosynthesis and increase in protein degradation have been proposed as the main pathogenic mechanisms, [19] [20] [21] mitochondrial dysfunction appears to be a key player in glucocorticoid-induced myopathy. In fact, morphologic changes in skeletal muscle mitochondria, decreased activity of mitochondrial enzymes, and mtDNA depletion, have all been described in patients with 'steroid' myopathy. [22] [23] [24] [25] To systematically study the contribution of mitochondrial genomics to human physiology and pathophysiology, we built a mitochondria-focused gene database and used it as reference for the development of a customized cDNA microarray (human mitochondria-focused cDNA microarray (hMitChip)), containing a large number of mitochondriarelated nuclear genes. To validate the ability of this mitochondrial microarray to detect changes in gene expression, we explored the pharmacogenomic effects of dexamethasone (Dex), a synthetic glucocorticoid, on the mitochondrial nuclear transcriptome in human skeletal muscle cells.
Results
High quality and consistency of hMitChip After printing, microarray quality control was performed by hybridization of multiple slides with 50 mg of Cy3-labeled sample cDNA and Cy5-labeled comparing cDNA using RNA extracted from two cancer cell lines (MDA-MB-231 and UACC903, ATCC, Manassas, VA, USA), followed by array scan and image analysis. The criteria for selection of highquality slides were: (a) clearly printed spots without smear and a full range (0-65535 pixel) distribution of signal intensities; (b) X3% of spots with saturated signals; and (c) average background intensities o1000 pixel when scanned at 90-95% laser power. 26 Scanning and computational analysis of the results generated from these experiments revealed strong signal intensities, low background noise and high consistency between duplicate spots in the array ( Figure 1 ).
Detection of significant changes in gene expression with hMitChip in human primary skeletal muscle cells Of the 501 mitochondria-related genes arrayed in hMitChip, 23 (4.5%) displayed significant transcriptional changes in skeletal myocytes after treatment with Dex (Table 1) . Upregulation of genes involved in amine metabolism (MAOA and SAT) was statistically significant at all time intervals tested, whereas for genes involved in protein processing (AKAP10), oxidative phosphorylation (FDX1, CYBA), heat shock cellular stress response (HSPD1), lipid biosynthesis (FACL2), glycolysis (GCK) and mitochondrial protein synthesis (TSFM) upregulation was stastistically significant only at certain time points. Treatment for 7 days downregulated genes related to lipid metabolism (ACADVL, ACADM), the tricarboxylic acid cycle (DLST), protein processing (MPI, PPIB) and gene transcription (GABPA), whereas it induced genes involved in apoptosis (BNIP3). The CTNNA1 and (AK1) genes, involved in cell adhesion and nucleotide metabolism, respectively, were also significantly downregulated after 7 days of exposure to 10 À6 M of Dex (Table 1) . Reproducible results were obtained across multiple replicate experiments, and after reverse labeling of the hybridized slides (Figure 2 ).
Confirmation by quantitative real-time polymerase chain reaction of microarray data generated with hMitChip in skeletal muscle cells For selected genes, the transcriptional changes detected with hMitChip were confirmed by QRT-PCR, carried out on RNA from the corresponding microarray experiments, as well as from separate time-course experiments, in which myocytes obtained from two independent healthy male donors were exposed to 10 À6 M of Dex for up to 9 days ( Figure 3) . A trend towards downregulation was observed for ACADVL and ACADM after 7 days of exposure to Dex, consistent with the microarray findings, but failed to reach statistical significance (data not shown). Quantitative realtime polymerase chain reaction results for selected genes, which were not differentially expressed in microarray experiments (i.e., NNT1, TOMM70) and were therefore used as negative controls, were also consistent with the microarray findings (data not shown).
Discussion
The increasing use of genomics in biomedical research presents new opportunities and challenges to scientists and clinicians worldwide. Transcriptional profiling of gene expression by DNA and protein microarrays allows high throughput screening, and helps identify molecular pathways with key functions in diverse physiologic and pathologic processes. These targets are then pursued as leads to help understanding the physiology and pathophysiology of such processes, and for potential diagnostic and therapeutic applications. 27 Admittedly, DNA microarray screening of large numbers of genes is a sophisticated 'fishing expedition', often challenged by complicated analyses, considerable experimental variability and, on occasion, poor reproducibility. These limitations may be partially circumvented by the use of focused microarrays incorporating selected genes of interest, which may offer a more 'hypothesis-driven' and less challenging, yet very effective, genomic exploratory tool.
Mitochondrial research has influenced concepts in human evolution, physiology and pathophysiology. The amount of biomedical research on mitochondria is rapidly growing, as witnessed by the recent flourishing of scientific literature in this field. An increasingly better understanding of the genetics and pathogenesis of inherited mitochondrial disorders, and the association of various degrees of mitochondrial function impairment with a constantly expanding list of common diseases, has certainly attracted the attention of the scientific and medical communities. 2 Other groups have previously reported on the development of customized mitochondrial microarrays. [28] [29] [30] Our findings indicate that, by allowing real-time transcriptional profiling of approximately 500 genes linked to mitochondrial structure, biogenesis and functions, hMitChip can provide a valid genomic instrument for mitochondrial research. A major effort was expended to identify appropriate candidate genes for inclusion in hMitChip. The original algorithm used combined the simplicity of keyword-based searches, aimed at localizing as many potentially relevant genes as possible, with a meticulous labor-intensive filtering of the collected information via review of data from the scientific literature; filtered data were cross-checked for consistency, and carefully categorized and subcategorized. 26 Fabrication of hMitChip was carried out to fulfill the highest standards in choice of manufacturing sources and materials, design, development and quality control. In addition to the mitochondrial nuclear genes, control elements were incorporated in each microarray slide for data correction, filtering and normalization. Furthermore, each spot was printed in duplicate as an additional internal control.
A dedicated software package was compiled to take these customized features into account in the computational analyses of the experimental results. Considering the completeness and organized structure of our database, the full integration of software and database offers a unique instrument allowing immediate interpretation and crossvalidation of gene expression data. In the current study, 4.5% of the genes screened exhibited significant transcriptional changes, in agreement with previous reports showing that fewer than 5% of genes are usually detected as differentially expressed in tightly designed experiments.
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Because of its focused repertoire, the number of differentially expressed genes detected by hMitChip was quite small and the expression pattern straightforward, as to eliminate the need for additional analyses (such as hierarchical clustering and/or multi-dimensional scaling), normally essential for a proper interpretation of data generated by large-scale microarray profiling. The high reliability of hMitChip, previously exhibited by quality control check in two cancer cell lines (MDA-MB-231 and UACC903), 26 was reconfirmed in primary skeletal myocytes. In addition to the high signal/noise ratios and comparability of experimental units and technical replicates, our results revealed significant reproducibility in biologic replicates, as witnessed by the consistency of QRT-PCR results generated on myocytes from three healthy male donors. These findings are of particular relevance, as biologic variability linked to cell/tissue source and donor effect is a major challenge in microarray experiments. Furthermore, the data indirectly suggest that hMitChip may be a reliable genomic tool for ex vivo transcriptional gene profiling in a clinical setting, wherein muscle biopsies are used for diagnostic purposes, such as in primary mitochondrial disorders.
Expression profiling by hMitChip in skeletal myocytes treated with pharmacologic doses of Dex revealed transcriptional adaptation of mitochondrial nuclear genes involved in important cellular processes, such as oxidative stress, lipid metabolism and apoptosis. Results on selected upregulated genes, such as MAOA, and to a lesser extent FDX1 and FACL2, were confirmed by QRT-PCR, providing further validation for hMitChip. Although more research is needed to corroborate the pathogenic and clinical relevance of these findings, they strongly suggest that these mitochondrial genes are important targets of glucocorticoid action in the skeletal muscle. Indeed, we recently corroborated and expanded our observation of MAOA upregulation by Dex in myocytes. 32 Monoamine oxidase A is the major catecholamine-metabolizing enzyme. 33 We demonstrated that the significant time-and dose-dependent transcriptional activation of MAOA by Dex is mediated by the glucocorticoid receptor, and paralleled by increased protein expression and enzymatic activity. The downstream result of this stimulatory effect is an increased MAOA-mediated H 2 O 2 generation. On the basis of these findings, we proposed that glucocorticoid-induced/MAOA-mediated increase in oxidative stress may be a previously unrecognized molecular mechanism relevant to the pathogenesis of glucocorticoid myopathy. 32 Our current findings are also consistent with previous reports on the role of glucocorticoids in the polyamine-and heat shock-induced cellular stress responses. Spermidine is one of the constituents of the polyamine stress response. 34 Dexamethasone has been shown to increase the concentrations of polyamines, including spermine and spermidine in the hippocampus of adult male mice. 35 In addition, the induction of hsp60 by Dex observed in the present study is consistent with that stimulated by methylprednisolone under hypoxic conditions in an isolated portally perfused rat liver model. 36 This induction was protective of mitochondrial membrane potential, integrity and capacity for ATP generation, which are crucial for the survival of cardiac myocytes undergoing ischemia/reperfusion. 37 Induction of PPIB (cyclophilin B) is another indicator of cellular stress caused by exposure to ROS, and is produced in parallel with hsp90 in response to oxidative stress. 38 Of interest is also the observed change in the expression of AK1, which is involved in nucleotide/ATP synthesis and is essential for muscle cellular energetics and performance. 39 The attenuated expression of genes involved in the degradation of medium and very long chain fatty acids (ACADM and ACADVL, respectively) is also concordant with previous reports on similar effects of glucocorticoids on liver fatty acid metabolism. 40 In contrast, genes like ACADC (also related to lipid degradation) and FACL2 (involved in lipid synthesis) were induced by Dex. The net effects of these changes on lipid metabolism warrant further investigation.
The growth-associated binding protein (GABP) is a ubiquitous transcription factor involved in the modulation of neuromuscular signaling. It consists of two subunits, GABPa (encoded by the GABPA gene), containing a characteristic DNA-binding domain, and GABPb, which lacks direct DNA-binding capacity, but enhance the DNA-binding activity of GABPa by forming heterocomplexes with it, and hMitChip: a mitochondria-focused human cDNA microarray S Alesci et al inducing their nuclear translocation. 41 There is evidence that GABP functions as a transcriptional activator for synaptic genes, including nicotinic acetylcholine receptor, acetylcholine esterase and utrophin. 42, 43 Thus, downregulation of the GABPA gene in skeletal myocytes after long-term exposure to Dex, as shown in our study, may indirectly reduce the transcription rate of these synaptic genes, potentially interfering with the nerve influx to the muscle. This hypothesis remains to be tested.
Bcl2/E1B 19 kDa interacting protein (BNIP3) is a member of the Bcl2 family upregulated during hypoxia. 44 Overexpression of BNIP3 promotes cell death through opening of the permeability transition pore, loss of membrane potential, and increased production of reactive oxygen species. 45 The BNIP3 gene appears to be involved in the hypoxia/ acidosis-induced cell death of cardiac myocytes. 46 Therefore, its induction by Dex may be pro-apoptotic for the skeletal myocyte.
In summary, the present results generated with hMitChip in primary human cells highlight the sensitivity, specificity and accuracy of hMitChip, and its potential usefulness in pharmaco-and mitogenomics. Integrating experimental data generated with hMitChip with those already included in our database will provide a powerful source of information to scientists and clinicians working in the mitochondrial field. In this context, we recently updated the database and have planned to make it available to the public via the Internet soon. During the update, we identified 523 additional genes newly linked to mitochondria. We will incorporate them, together with the 37 mtDNA genes custom cloned by our group, into the next generation of hMitChip. This major upgrade will hopefully allow inter-genomic studies of the entire mitochondrial transcriptome.
Materials and methods

Compilation of a human mitochondria-focused gene database
We constructed a human mitochondria-focused gene database to be used as an accurate, updated and non-redundant reference source for the development of hMitChip. Potential candidate genes were identified by keyword-based searches performed in various online gene databases (i.e., euGenes, 47 GeneCards, 48 UniGene, LocusLink, OMIM, HomoloGene, 49 GDB, 50 SOURCE, 51 and GeneLynx
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). The inclusion of selected genes was further validated by an in depth review of the scientific literature, using both online sources (i.e., PubMed, 49 Cochrane Library, 53 OVID, 54 The Web of Science 55 ) and textbooks. [56] [57] [58] [59] After cross-checking for errors, consistency, and validation of symbols and identifiers, genes were organized into 15 categories and 24 subcategories classified by biologic process involved and molecular function, according to both the Gene Ontology Consortium's guidelines 60 and our review of the literature. The database was compiled using a commercially available software package (FileMaker Pro 6.0, FileMaker Inc., Santa Clara, CA, USA). 26 Fabrication of human a mitochondria-focused cDNA microarray Human mitochondria-focused cDNA microarray was developed according to previously published methods. 61 A total of 501 mitochondria-related human cDNA clones (see Supplementary Information) and 192 control elements were used to fabricate hMitChip. All of the clones were purchased from sequence verified human cDNA libraries (Invitrogen Inc., Carlsbad, CA, USA). Plasmid DNA, containing human cDNA inserts, was isolated from E. coli host cells by standard methods. cDNA inserts were amplified by PCR, using the vector sequence-specific primers (5 0 -ctgcaaggcgattaagttgggtaac-3 0 and 5 0 -gtgagcggataacaatttcacacaggaaacagc-3 0 ). After PCR amplification of the clones, 5 of the 80 ml of PCR product solution were used for electrophoretic analysis, to verify the amplification. Each of the non-amplified cDNA clones was individually re-processed, until the desired product was obtained. The remaining 75 ml of PCR products were dissolved into ddH 2 O after purification, to determine DNA concentration. The DNA concentration was then adjusted to 200 ng DNA/ml in 3 Â SSC buffer. This concentration was used to print the microarrays on pre-processed microscopy glass slides (75 Â 25 mm 2 ) coated with poly-Llysine as previously described, 61 using the OmniGrid Microarrayer from Genomic Solutions (Ann Arbor, MI, USA). All spots were printed in duplicate onto the glass slides.
The 192 control elements included: (a) 96 'housekeeping' genes (see Supplementary Information) for expression ratio control; (b) 24 spots of printing buffer (no DNA) for background control; (c) 24 spots of human Cot-1 DNA for blocking repetitive DNA control (hybridization buffer containing Cot-1 DNA); (d) 24 spots of human placental genomic DNA for identical and homologous sequence 'cross-hybridization' control; (e) 24 spots of plasmid vector pBluescript DNA as control for nonspecific 'cross-hybridization'. 26 Cell culture and treatment Primary human myoblasts derived from vastus lateralis muscle biopsies of three healthy male donors (16, 25 and 30 years of age), were purchased from Clonetics s (Cambrex BioScience Inc., Walkersville, MD, USA). Myoblasts were grown in basal medium, supplemented with 10% fetal bovine serum (FBS), Dex, hrEGF, amphotericin/gentamycin, penicillin/streptomycin and L-glutamine (SkMC-Bullet-kit, Cambrex, Bioscience Inc., Walkersville, MD, USA) at 371C in a 5% CO 2 atmosphere. Differentiation of myoblasts into myocytes was induced at 80710% confluence, by replacing the growth medium with high glucose Dulbecco's-modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, CA, USA) supplemented with 2% horse serum and penicillin/streptomycin. Myoblasts fused to multinucleated myotubes after 4-5 days. On day 5 of differentiation, myocytes were treated with 10 À6 M of Dex for up to 9 days. Culture medium supplemented with 10% FBS was used for the longer treatment periods to avoid any interference on the experimental findings related to apoptosis induced by serum deprivation. 62, 63 Myocytes used for microarrays derived hMitChip: a mitochondria-focused human cDNA microarray S Alesci et al from a single donor (16-year old), whereas those used for QRT-PCR were from all of the three donors. At least three separate experiments in triplicate were performed.
RNA extraction, probe labeling and hybridization Total RNA was isolated from untreated and Dex-treated myocytes using the TRIzol reagent (Invitrogen Inc.), and purified using the RNeasy Midi columns (Qiagen Inc., Valencia, CA, USA) according to the manufacturer's instructions. RNA was quantified by optical density at 260 nm, using the SpectroMax Plus spectrophotometer (Molecular Devices, Sunnyvale, CA, USA), and tested for integrity by denaturing gel electrophoresis. Fluorescent cDNA preparation and hybridization with the arrayed cDNAs were performed using the MICROMAX MPS502 direct labeling kit (Perkin Elmer Life Sciences Inc., Wellesley, MA, USA). Briefly, 25 mg of total RNA was labeled with fluorescent nucleotides Cy5-dUTP and Cy3-dUTP using oligo-primers and reverse transcriptase. The reaction was stopped by addition of 5 ml of 500 mM EDTA. The cDNA was then hydrolyzed by adding 5 ml of 1M NaOH and heating at 651C for 30 min. 13 ml of 1M Tris-HCl, were used to partially neutralize the base. Unincorporated nucleotides and salts were removed with the Microcon YM-100 columns (Millipore, Billerica, MA, USA). Probes were dried in a Speed-Vac apparatus and re-dissolved in 16 ml of hybridization buffer at 421C for 10 min. Probes were incubated at 951C for 2 min and put on ice before being placed onto the microarray glass slides and covered with a cover slip. Hybridization was performed at 651C for 12-14 h. For each experimental condition, triplicate sets of slides were hybridized (at least two forward and one reverse hybridization) with RNA obtained from three separate experiments on different cell subpopulations (biological replicates) or, in selected cases, with multiple aliquots of RNA obtained from the same experiment (technical replicates). Following hybridization, slides were washed in 0.5% SSC/0.01% SDS, 0.5% SSC, 0.1% SSC and 0.06% SSC, each for 3 min and in 0.01% SSC for 10 s, and then dried by centrifugation at 1500 r.p.m. for 5 min. For each slide, the two fluorescent intensities (Cy3 and Cy5) were scanned separately with the ScanArray Express scanner (Perkin Elmer Life Sciences) for gene expression comparison.
Quantitative real-time polymerase chain reaction analysis of gene expression for selected genes, expression data generated by microarray experiments were confirmed by QRT-PCR. First-strand cDNA was generated from total RNA samples using the Superscript III RNAse H-reverse transciptase kit (Invitrogen Inc.). RNA was obtained from the same samples used for microarrays (technical replicates), as well as from three independent experiments performed on cells derived from the three donors at different passages (true biological replicates). Briefly, 1.5 mg of RNA were mixed with 150 ng of random primers, 10 U of ribonuclease inhibitor rRNAsin s (Promega, Madison, WI, USA), and 50 U of Superscript III in a reverse transcriptase reaction buffer (50 mM Tris-HCl, 75 mM KCl, 5 mM MgCl, 10 mM dNTPs, 0.1 M DTT). The SYBR Green PCR Core reagents kit and the ABI Prism 7900 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) were employed to estimate the mRNA of interest compared with a reference control. Next, the cDNA obtained from reverse transcription was combined with a QRT-PCR reaction mixture consisting of 3 mM MgCl 2 , 1 mM dNTPs, 0.025 U/ml AmpliTaq-Gold s DNA polymerase and 0.01 U/ml AmpErase (Applied Biosystems). The following amplification settings were used: 501C/2 min, 951C/10 min, 951C/15 s and 621C/1 min for 55 cycles, followed by a dissociation stage.
Oligonucleotide primers were designed using the Primer Express software (Applied Biosystems) and selected to span at least one intron, in order to avoid genomic amplification from possible contaminating DNA, carried over from the RNA isolation step. The human acidic ribosomal phosphoprotein P0 (RPLP0, GenBank accession number: NM_053275) was used as control gene to normalize for variations in the amount of starting material in each PCR reaction. Primer pairs for control and tested genes used in the current study are shown in Table 2 .
Dissociation curve analysis was run to ensure that a single product and no primer-dimers were present after each experiment. The size of the QRT-PCR products was verified by electrophoresis on 4% agarose gels. Fluorescence signals, which are proportional to the concentration of the products, were measured at the end of each cycle, displayed, and analyzed with the Applied Biosystem 7900 Sequence Detection System companion software package. The threshold cycle number (C T ) generated for each gene was used to quantify its relative abundance. The normalized threshold cycle number, DC T, was calculated as
. The abundance of the gene of interest in Dextreated cells was calculated relatively to that in untreatedcontrol cells, assuming an optimal amplification efficiency close to one: relative abundance ¼ 2
ÀDDCT
, where
. 64, 65 Image and data analyses Scanned microarray images were analyzed using the QuantArray software (Perkin Elmer Life Sciences). DNA spots were automatically segmented, local background was subtracted and LOWESS normalization applied, in order to calculate the total intensity and intensity ratios of the two dyes for each target. Ratio calibration was performed based on preselected housekeeping control genes, whose ratios were normalized close to a value of 1. A 99% confidence interval was used to determine significantly up-or downregulated genes.
Selection of statistically significant changes in gene expression followed a two-step process. Differentially expressed genes were initially selected based on the following criteria: (a) Genes with 425% foreground pixels or signal intensities in both the Cy3 and Cy5 channels for each arrayed spot having 42 s.d. over the background mean; (b) Genes with o2-fold changes between duplicate sets on the same slide; (c) Genes with at least 1.6-fold up-or downregulation. To assess the similarity of gene expression levels hMitChip: a mitochondria-focused human cDNA microarray S Alesci et al between the duplicate sets on each array, scatter plots were used in which each gene was plotted by its two expression intensities on a log scale. Consistency (R 2 40.92) between the duplicate spots on each array was considered essential for inclusion of individual experiments in the subsequent analyses. These criteria allowed us to eliminate control spots, genes with low signal/noise ratios, and genes with signal inconsistencies between duplicate spots. In the second step, all of the selected genes were used to tabulate normalized mean expression ratios, derived from the QuantArray export data, between Cy5-and Cy3-labeled samples from triplicate experiments, including inverted ratios from the reverse labeling. A customized Microsoft Excel macro was written to compute and compare the normalized mean and median intensities, their s.d., the signal/noise ratios, and scatter plots of the correlations between duplicate sets of genes. Normalized mean ratios and s.d., calculated from duplicates and reverse labeled slides, were used for group comparison analysis by the Student's t-test.
For results generated by QRT-PCR, the distributional assumption of normality was checked using normal probability plots and the Shapiro-Wilkes test; log-10 transformation was applied whenever this assumption was not met. ANOVA was subsequently performed with fold change in gene expression and DC T as dependent variables. The donor effect was tested and determined not to be significant. The Turkey-Kramer procedure was used to test for multiple comparisons. In the case of highly skewed data, the non-parametric, k-means Kruskal-Wallis test was also performed.
The level of statistical significance was set at Po0.05 after adjustments for multiple comparisons. 
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